Signet Investment Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Signet Investment Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Sell	5,978 -170	-3%	-$9.76K	0.15%	64
2026 Q1	$373K	Hold	6,148	–	–	0.17%	59
2025 Q4	$332K	Hold	6,148	–	–	0.15%	62
2025 Q3	$277K	Hold	6,148	–	–	0.13%	65
2025 Q2	$285K	Sell	6,148 -76	-1%	-$3.73K	0.15%	62
2025 Q1	$380K	Sell	6,224 -2,037	-25%	-$119K	0.19%	59
2024 Q4	$467K	Buy	8,261 +189	+2%	+$10.6K	0.24%	60
2024 Q3	$418K	Sell	8,072 -45	-0.6%	-$2.11K	0.21%	61
2024 Q2	$337K	Sell	8,117 -50	-0.6%	-$2.24K	0.18%	61
2024 Q1	$443K	Sell	8,167 -5	-0.1%	-$255	0.24%	59
2023 Q4	$419K	Buy	8,172 +200	+3%	+$10.5K	0.25%	60
2023 Q3	$463K	Buy	7,972 +175	+2%	+$10.7K	0.31%	58
2023 Q2	$499K	Hold	7,797	–	–	0.33%	56
2023 Q1	$540K	Sell	7,797 -5	-0.1%	-$353	0.37%	56
2022 Q4	$561K	Sell	7,802 -1,795	-19%	-$135K	0.4%	57
2022 Q3	$682K	Sell	9,597 -325	-3%	-$23.6K	0.53%	53
2022 Q2	$764K	Sell	9,922 -1,608	-14%	-$122K	0.53%	55
2022 Q1	$842K	Sell	11,530 -35	-0.3%	-$2.35K	0.51%	56
2021 Q4	$721K	Buy	11,565 +435	+4%	+$25.5K	0.41%	59
2021 Q3	$659K	Buy	11,130 +1,995	+22%	+$131K	0.42%	59
2021 Q2	$610K	Sell	9,135 -290	-3%	-$18.9K	0.39%	64
2021 Q1	$595K	Buy	9,425 +485	+5%	+$30.2K	0.46%	57
2020 Q4	$555K	Buy	+8,940	New	+$550K	0.44%	52
2019 Q4	$555K	Buy	8,655 +2,060	+31%	+$118K	0.52%	54
2019 Q3	$334K	Buy	6,595 +1,095	+20%	+$51.5K	0.34%	59
2019 Q2	$249K	Buy	5,500 +950	+21%	+$44.3K	0.26%	63
2019 Q1	$217K	Buy	4,550 +1,450	+47%	+$72.2K	0.23%	66
2018 Q4	$161K	Buy	+3,100	New	+$167K	0.18%	71

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Signet Investment Advisory Group's BMY Position: Q2 2026 in Review

Signet Investment Advisory Group reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $9.76K and leaving 5,978 shares worth $344K. The position accounts for 0.15% of the portfolio, ranked #64.

Signet Investment Advisory Group first reported a position in BMY in Q4 2018 and has held it in 28 quarters since. The position peaked at $842K in Q1 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Signet Investment Advisory Group held 5,978 shares of Bristol-Myers Squibb worth $344K as of Q2 2026.
Signet Investment Advisory Group sold 170 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.76K.
Bristol-Myers Squibb made up 0.15% of Signet Investment Advisory Group's portfolio in Q2 2026, its #64 holding.
Signet Investment Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 28 quarters since.
Signet Investment Advisory Group's Bristol-Myers Squibb position peaked at $842K in Q1 2022.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Signet Investment Advisory Group's 13F filing for Q2 2026, filed 30 Jul 2026.